The New API Facility is constructed on an existing site of RPG. Area of production block is approx. 1500 Sq.M. It was completed within 14 months and the facility cost of Rs. 180 million.
It is an USFDA approvable facility.
The new facility has two modules, one dedicated for manufacturing Azathioprine, and another for manufacturing multi-products like Haloperidole, Risperidone, Lamotrigine, etc. The project was unique since we had to fit the layout within the working site using existing utilities without any major shutdown except for hook-up
SPECTRUM planned the layout with central enclosed pipe rack for two modules with service area. This resulted in reduction in total piping and cabling costs.
Enclosed systems such as condensers were taken out of reactor area; this resulted in improved clean ability of reaction area.
A multi utility header was provided in the service area with pneumatic operations. These valves were interlinked to avoid mix-up of utilities during utility change over. |